Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06550050 · ClinicalTrials.gov registry record
Clinical and Molecular Features of Oral Premalignancy and Oral Cancer
A clinical trial of Oral Cancer, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT06550050 is a study of Oral Cancer that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 1,000 participants, above the 154-participant average among 17 other Oral Cancer trials with a reported enrollment target (549% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06550050, a study of Oral Cancer, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Investigators will employ serial assessments of tissue biopsy and additional biomarkers that reflect burden of disease and predict treatment response. Patients enrolled on this study will be given the option to provide biological samples before, during, and after treatment, as well as functional outcomes of treatment response. These samples will be utilized to develop and validate prognostic and predictive biomarkers for patients undergoing targeted therapy, immunotherapy, surgery, chemotherapy, and/or radiotherapy.
Conditions Studied
Interventions
- BEHAVIORAL Radiation
Study Locations (1)
Texas
- MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2024-10-31 |
| Est. Completion | 2066-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06550050
The ClinicalTrials.gov registry entry for NCT06550050 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 154-participant average among 17 other Oral Cancer trials with a reported enrollment target (549% higher). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Oral Cancer appearing as the primary indexed condition, and to 1 intervention - of which Radiation is the first listed.
NCT06550050 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06550050 about?
NCT06550050 is a clinical study titled "Clinical and Molecular Features of Oral Premalignancy and Oral Cancer". Investigators will employ serial assessments of tissue biopsy and additional biomarkers that reflect burden of disease and predict treatment response. Patients enrolled on this study will be given the option to provide biological samples before, during, and after treatment, as well as functional out...
What is the current status of trial NCT06550050?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2024-10-31. Estimated completion is 2066-12-31.
What conditions does trial NCT06550050 study?
This clinical trial studies the following conditions: Oral Cancer.
What interventions are being tested in trial NCT06550050?
The interventions under investigation include: Radiation (BEHAVIORAL).
Who is sponsoring clinical trial NCT06550050?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06550050 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Oral Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Surgeon-performed Ultrasound for Real-time Guidance In Oral Cancer Surgeries - A Multicenter Randomized Controlled Trial
RECRUITING · NA
-
Defining Mechanisms of Surgical Site Infection After Oral Cancer Surgery
RECRUITING
-
Defining TRPV4 Contribution of Schwann Cells to Oral Cancer Pain
RECRUITING · NA
-
Prosthesis Guided Speech Rehabilitation of T1/T2 Cancers of the Tongue
RECRUITING · NA
-
Tongue Proactive Strengthening Exercise Program Following Partial/Hemi Glossectomy and Reconstruction
RECRUITING · NA
-
Antibiotic Treatment Effects on Intratumoral Bacteria Modulation in Surgical Patients With Oral Cancer
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.